275 related articles for article (PubMed ID: 31812004)
1. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
Maher HM; Alzoman NZ; Shehata SM
J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
[TBL] [Abstract][Full Text] [Related]
4. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
Bouchet S; Chauzit E; Ducint D; Castaing N; Canal-Raffin M; Moore N; Titier K; Molimard M
Clin Chim Acta; 2011 May; 412(11-12):1060-7. PubMed ID: 21345336
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
8. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study.
Stancil SL; van Haandel L; Abdel-Rahman S; Pearce RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():272-278. PubMed ID: 29933220
[TBL] [Abstract][Full Text] [Related]
9. Eco-Friendly, Simple, Fast, and Sensitive UPLC-MS/MS Method for Determination of Pexidartinib in Plasma and Its Application to Metabolic Stability.
Ezzeldin E; Iqbal M; Asiri YA; Mostafa GAE; Sayed AYA
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011540
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.
Ni MW; Zhou J; Li H; Chen W; Mou HZ; Zheng ZG
Bioanalysis; 2017 Jun; 9(12):925-935. PubMed ID: 28617069
[TBL] [Abstract][Full Text] [Related]
11. UPLC-MS/MS determination of phentolamine in human plasma and its application to a pharmacokinetic study.
Kan X; Zheng SL; Zhou CY
Drug Res (Stuttg); 2014 Nov; 64(11):607-12. PubMed ID: 24452521
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.
Huynh HH; Pressiat C; Sauvageon H; Madelaine I; Maslanka P; Lebbé C; Thieblemont C; Goldwirt L; Mourah S
Ther Drug Monit; 2017 Feb; 39(1):43-54. PubMed ID: 27861317
[TBL] [Abstract][Full Text] [Related]
13. Rapid determination of ruscogenin in rat plasma with application to pharmacokinetic study.
Ji PY; Li ZW; Yang Q; Wu R
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():71-4. PubMed ID: 25660717
[TBL] [Abstract][Full Text] [Related]
14. Novel high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton's tyrosine kinase inhibitors and their three active metabolites in human plasma.
Mukai Y; Yoshida T; Kondo T; Inotsume N; Toda T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121928. PubMed ID: 31877431
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
Ren H; Qian D; Su S; Guan H; Zhang W; Shang E; Duan J
Drug Test Anal; 2016 Jul; 8(7):744-54. PubMed ID: 26382027
[TBL] [Abstract][Full Text] [Related]
16. A rapid UHPLC-MS/MS method for the quantification of ARQ531 in rat plasma: Validation and its application to a pharmacokinetic study.
Liu J; Ji M; Li Z; Xu X; Li L; Li H; Tian Y; Su X
Biomed Chromatogr; 2020 Nov; 34(11):e4937. PubMed ID: 32614971
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a sensitive LC-MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studies.
He Y; Zhou L; Gao S; Yin T; Tu Y; Rayford R; Wang X; Hu M
J Pharm Biomed Anal; 2018 Jan; 148():65-72. PubMed ID: 28965046
[TBL] [Abstract][Full Text] [Related]
18. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
Koller D; Vaitsekhovich V; Mba C; Steegmann JL; Zubiaur P; Abad-Santos F; Wojnicz A
Talanta; 2020 Feb; 208():120450. PubMed ID: 31816725
[TBL] [Abstract][Full Text] [Related]
19. Ultra-performance liquid chromatography/tandem mass spectrometry method for the determination of lercanidipine in human plasma.
Kalovidouris M; Michalea S; Robola N; Koutsopoulou M; Panderi I
Rapid Commun Mass Spectrom; 2006; 20(19):2939-46. PubMed ID: 16941725
[TBL] [Abstract][Full Text] [Related]
20. Determination of kurarinone in rat plasma by UPLC-MS/MS.
Zhang WM; Li RF; Qiu JF; Zhang ZY; Wang HB; Bian L; Lei JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():31-4. PubMed ID: 25703950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
